A groundbreaking cannabinoid-based antimicrobial, Silvanex, fights drug-resistant infections with a synergy of silver, CBC and CBG.
Recognising challenges presented by toxin- and enzyme-producing pathogens such as Pseudomonas aeruginosa and MRSA, SolasCure ...